STATE STREET CORP - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 147 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.16 and the average weighting 0.6%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$51,220,756
+32.5%
1,620,910
+8.5%
0.00%
+50.0%
Q2 2023$38,660,568
+37.5%
1,494,417
+27.7%
0.00%0.0%
Q1 2023$28,113,609
-59.0%
1,170,425
-66.7%
0.00%0.0%
Q4 2022$68,586,102
+230.1%
3,517,236
+255.6%
0.00%
+100.0%
Q3 2022$20,778,000
+287.1%
988,962
+258.5%
0.00%
Q2 2022$5,368,000
+83.6%
275,867
+107.8%
0.00%
Q1 2022$2,923,000
+48.1%
132,744
+7.3%
0.00%
Q4 2021$1,974,000
-22.0%
123,735
-2.6%
0.00%
Q3 2021$2,532,000
+16.4%
127,089
+1.0%
0.00%
Q2 2021$2,175,000
+21.1%
125,786
+38.8%
0.00%
Q1 2021$1,796,000
+8.3%
90,618
-4.6%
0.00%
Q4 2020$1,659,000
-16.3%
95,018
-7.6%
0.00%
Q3 2020$1,981,000
+6.4%
102,803
+7.5%
0.00%
Q2 2020$1,861,000
+164.7%
95,655
+90.4%
0.00%
Q1 2020$703,000
+25.5%
50,228
+120.1%
0.00%
Q4 2019$560,000
+184.3%
22,819
+16.3%
0.00%
Q3 2019$197,00019,6160.00%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,621,118$38,939,25445.05%
NEA Management Company, LLC 4,186,243$100,553,5576.95%
Frazier Life Sciences Management, L.P. 3,860,107$92,719,7706.71%
Prosight Management, LP 567,826$13,639,1816.47%
TANG CAPITAL MANAGEMENT LLC 1,170,000$28,103,4004.19%
Highlander Partners, L.P. 122,980$2,953,9804.00%
Novo Holdings A/S 1,684,193$40,454,3162.67%
CADIAN CAPITAL MANAGEMENT, LP 734,922$17,652,8261.10%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,032,335$48,816,6871.09%
SILVERARC CAPITAL MANAGEMENT, LLC 105,939$2,544,6551.05%
View complete list of MIRUM PHARMACEUTICALS INC shareholders